Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04125420 · ClinicalTrials.gov registry record
Hypersensitivity Reactions During Anesthesia
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 940
- Enrollment target
NCT04125420: Completed study, sponsored by Mayo Clinic.
NCT04125420 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 940 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04125420 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 940 participants
- Enrollment target
Study Summary
Researchers are trying to study the natural history of allergic reactions during anesthesia and its causes and risk factors.
Primary Outcome
Current estimates are between 1:400 to 1:10,000 surgeries mostly based on retrospective reviews. We will report incidence based on numbers of event/number of surgeries
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 940 participants |
| Start Date | 2018-08-03 |
| Est. Completion | 2022-02-01 |
What the finished NCT04125420 record still lists
NCT04125420 is an observational study that tracks outcomes without assigning an intervention. The registered 940 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04125420 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04125420 about?
NCT04125420 is a clinical study titled "Hypersensitivity Reactions During Anesthesia". Researchers are trying to study the natural history of allergic reactions during anesthesia and its causes and risk factors.
What is the current status of trial NCT04125420?
This trial is currently completed. The enrollment target is 940 participants. The study started on 2018-08-03. Estimated completion is 2022-02-01.
Who is sponsoring clinical trial NCT04125420?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03075696 · 940 participants · Phase 1
A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma
- NCT06855277 · 940 participants · Phase 3
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- NCT06808334 · 942 participants
CLAiR Pivotal Study
- NCT07190209 · 942 participants · Phase 3
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI